Harvard Bioscience Inc
(NASDAQ:HBIO)
$5.22
0.29[5.88%]
Last update: 4:00PM (Delayed 15-Minutes)
Get Real Time Here
$5.22
0[0.00%]
After-Hours
Open4.980Close5.220
Vol / Avg.113.269K / 90.463KMkt Cap222.833M
Day Range4.915 - 5.30052 Wk Range1.990 - 6.290

Harvard Bioscience Stock (NASDAQ:HBIO), Analyst Ratings, Price Targets, Predictions

Analysts publish ratings and price targets on most stocks. Benzinga tracks 120 analyst firms so investors can understand if analysts expect a stock to trade higher or lower. Ratings are directional and typically buy, sell or hold. Price Targets are an analyst's best guess at where the stock will trade in 12 months.

Consensus Rating1

Overweight

Highest Price Target1

$7.00

Lowest Price Target1

$4.00

Consensus Price Target1

$6.00

Analyst Rating Summary1

BuyOverweightHoldUnderweightSell
11000

Analyst Firms Making Recommendations1

  • Benchmark
  • Keybanc

1calculated from analyst ratings published within the last 3 years

Analyst Ratings for Harvard Bioscience

Upgrades (0)

Downgrades (0)

Initiations (0)

date
ticker
Buy Now
Company
Current price
Upside/Downside
Analyst Firm
Analyst & % Accurate
Price Target Change
Rating Change
Previous / Current Rating
Get Alert
06/22/2023HBIOBuy Now
Harvard Bioscience
$5.2234.1%Benchmark
Bruce Jackson
→ $7ReiteratesSpeculative Buy → Speculative BuyGet Alert
04/26/2023HBIOBuy Now
Harvard Bioscience
$5.2234.1%Benchmark
Bruce Jackson
$4 → $7MaintainsBuyGet Alert
04/26/2023HBIOBuy Now
Harvard Bioscience
$5.2234.1%Keybanc
Paul Knight
$5 → $7MaintainsOverweightGet Alert
03/10/2023HBIOBuy Now
Harvard Bioscience
$5.22-23.37%Benchmark
Kenneth Bruce
→ $4Reiterates → BuyGet Alert
11/09/2022HBIOBuy Now
Harvard Bioscience
$5.22-4.21%Keybanc
Paul Knight
$7 → $5MaintainsOverweightGet Alert
08/05/2022HBIOBuy Now
Harvard Bioscience
$5.2234.1%Keybanc
Paul Knight
$10 → $7MaintainsOverweightGet Alert
Q

What is the target price for Harvard Bioscience (HBIO)?

A

The latest price target for Harvard Bioscience (NASDAQ: HBIO) was reported by Benchmark on June 22, 2023. The analyst firm set a price target for $7.00 expecting HBIO to rise to within 12 months (a possible 34.10% upside). 4 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Harvard Bioscience (HBIO)?

A

The latest analyst rating for Harvard Bioscience (NASDAQ: HBIO) was provided by Benchmark, and Harvard Bioscience reiterated their speculative buy rating.

Q

When is the next analyst rating going to be posted or updated for Harvard Bioscience (HBIO)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Harvard Bioscience, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Harvard Bioscience was filed on June 22, 2023 so you should expect the next rating to be made available sometime around June 22, 2024.

Q

Is the Analyst Rating Harvard Bioscience (HBIO) correct?

A

While ratings are subjective and will change, the latest Harvard Bioscience (HBIO) rating was a reiterated with a price target of $0.00 to $7.00. The current price Harvard Bioscience (HBIO) is trading at is $5.22, which is within the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.